BioLineRx Ltd. Ratios

Ratios Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 23.08%67.99%
EBT Margin -988.54%-796.57%-3,751.56%-15,179.25%-74,959.09%-120,090.48%-5,313.32%-1,134.56%-1,307.43%-2,362.92%-1,251.11%-990.10%-39.01%
EBIT Margin -1,088.54%-896.57%-3,851.56%-15,279.25%-75,059.09%-120,190.48%-5,413.32%-1,234.56%-1,407.43%-2,462.92%-1,351.11%-1,035.29%-70.52%
EBITDA Margin -1,018.04%-839.59%-3,104.91%-13,584.91%-72,004.55%-120,190.48%-5,413.32%-1,234.56%-1,407.43%-2,462.92%-1,351.11%-1,035.29%-70.52%
Operating Margin -1,088.54%-896.57%-3,851.56%-15,279.25%-75,059.09%-120,190.48%-5,413.32%-1,234.56%-1,407.43%-2,462.92%-1,351.11%-1,035.29%-70.52%
Net Margin -988.54%-796.57%-3,751.56%-15,179.25%-74,959.09%-120,090.48%-5,313.32%-1,134.56%-1,307.43%-2,362.92%-1,251.11%-990.10%-39.01%
FCF Margin -995.07%-1,024.78%-3,473.88%-15,897.17%-66,204.55%-102,604.76%-5,151.16%-998.38%-1,424.55%-2,352.88%-1,222.01%-473.42%-151.78%
Efficiency
Inventory Average 2.55M
Assets Average 51.42M
Equity Average 196.15M
Invested Capital 393.75M6.17M
Asset Utilization Ratio 0.56
Leverage & Solvency
Interest Coverage Ratio 10.898.9738.52152.79750.590.00M54.1312.3514.0724.6313.5122.912.24
Debt to Equity 0.037.95
Debt Ratio 0.150.35
Equity Ratio 6.110.04
Times Interest Earned 10.898.9738.52152.79750.590.00M54.1312.3514.0724.6313.5122.912.24
Valuation
Enterprise Value 31.27M51.62M39.12M50.85M50.43M111.04M45.94M22.34M49.81M96.44M36.30M54.25M-2.45M
Market Capitalization 31.27M51.62M39.12M50.85M50.43M111.04M45.94M22.34M49.81M96.44M36.30M97.24M17.11M
Return Ratios
Return on Sales -9.89%-7.97%-37.52%-151.79%-749.59%-53.13%-11.35%-13.07%-23.63%-12.51%-9.90%-0.39%
Return on Capital Employed -0.57%
Return on Assets -0.22%
Return on Equity -0.06%